LF READER

COVID-19 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) (For LF Reader) (Qualitative Result)

COVID-19 and Influenza A+B Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens present in human nasopharyngeal swab specimens that can be performed with the use of the LF Reader.

Product Features

Fast results

Simple Operation (Less Training Required)

Objective (Results Read by Analyzer)

High Accuracy




Product Specification

  • PrincipleChromatographic Immunoassay
  • FormatCassette
  • SpecimenNasopharyngeal Swab
  • CertificateCE
  • Reading Time15 minutes
  • Pack20 T
  • Storage Temperature2-30°C
  • Shelf Life2 Years
  • Sensitivity97.1%(COVID-19) / 95.0%(Influenza A) / 92.9%(Influenza B)
  • Specificity99.1%(COVID-19) / 99.1%(Influenza A) / 99.1%(Influenza B)
  • Accuracy98.2%(COVID-19) / 98.4%(Influenza A) / 98.1%(Influenza B)

Ordering Information

Cat. No. Product Specimen Pack Cut-Off
ICIC-R525 COVID-19 and Influenza A+B Antigen Combo Rapid Test Nasopharyngeal Swab 20 T -

Other products